Status:
RECRUITING
GMMG Multiple Myeloma Registry
Lead Sponsor:
Prof. Dr. Hartmut Goldschmidt
Collaborating Sponsors:
Dietmar Hopp Stiftung
KKS Netzwerk
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Gr...
Detailed Description
The German-speaking Myeloma Multicenter Group (GMMG) registry is a national, observational, non-interventional, retro-and prospective clinical myeloma registry of multiple myeloma patients in Germany....
Eligibility Criteria
Inclusion Criteria:
- Previous participation in a a therapy study of the GMMG study group
Exclusion Criteria:
- patients with organ amyloidosis at time of diagnosis
Key Trial Info
Start Date :
December 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
999 Patients enrolled
Trial Details
Trial ID
NCT07111884
Start Date
December 8 2022
End Date
March 1 2027
Last Update
August 8 2025
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
HELIOS Klinikum, Klinik für Hämatologie, Onkologie und Immunologie
Berlin, Germany, 13125
2
Charité Campus Benjamin Franklin, III. Med. Abt. (Hämatologie/Onkologie)
Berlin, Germany, D-12200
3
Klinikum Bielefeld, Klinik für Hämatologie, Onkologie und Palliativmedizin
Bielefeld, Germany, D-33604
4
Medizinische Universitätsklinik, Knappschaftskrankenhaus
Bochum, Germany, D-44892